Liquid Holdings Group Prices Initial Public Offering NEW

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Liquid Holdings Group Prices Initial Public Offering

NEW YORK, July 26, 2013 (GLOBE NEWSWIRE) -- Liquid Holdings Group, Inc. ("Liquid") (Nasdaq: LIQD ), a provider of cloud-based execution and order management, risk and shadow accounting systems for the financial services community, announced the pricing of its initial public offering of 3,175,000 shares of its common stock at $9.00 per share. In addition, Liquid has granted the underwriter a 30-day option to purchase up to an additional 464,238 shares of common stock to cover over-allotments, if any. All of the shares are being offered by Liquid. The shares of common stock will trade on the NASDAQ Global Market under the symbol "LIQD."

Sandler O'Neill + Partners, L.P. is the sole book-running manager. The offering of these securities is being made only by means of a prospectus. A copy of the final prospectus related to the offering will be filed with the Securities and Exchange Commission and may be obtained, when available, from: Sandler O'Neill + Partners, L.P., 1251 Avenue of the Americas, 6th Floor, New York, NY 10020, Attention: Prospectus Department, or calling toll-free 1-866-805-4128 or emailing syndicate@sandleroneill.com .

A registration statement relating to these securities has been filed and declared effective by the Securities and Exchange Commission. This release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

LIQD-F

Investor Relations: Monica Gould The Blueshirt Group +1 212 871-3927 Media Relations: Kim Hughes The Blueshirt Group +1 415 516-6187

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Ovation's Roadmap for Revitalizing Rural Healthcare

Updated Category News Views 5

Steering Rural Healthcare Towards a Brighter Future Alright, here we are with Ovation Healthcare trying to inject some much-needed life into the sometimes forgotten corners of the healthcare world—those rural hospitals. They’ve cooked up a fresh white paper, and it’s got the makings of a lifeline for these institutions swirling in red ink. The financial landscape...

Continue Reading
ProperHeir Expands with New Innovative Office Space

Updated Category News Views 194

ProperHeir Expands with New Innovative Office Space ProperHeir has recently announced an exciting development with the opening of its new office at the Miramar Tech Center. This expansion marks a significant milestone as the company has tripled its available space. The chief purpose of this new office is to effectively host its growing in-house sales team and provide a...

Continue Reading
Discover How Octa Transforms Forex Trading for Singaporeans

Updated Category News Views 95

Understanding the Forex Market The foreign exchange market, commonly known as forex, stands as the largest and most dynamic financial market in the world. It allows traders to buy and sell currencies, leveraging the fluctuations in exchange rates to boost their earnings. Operating continuously from Monday to Friday, this market presents individual traders with the chance...

Continue Reading
Seoul Business Agency Powers Startups at the CES 2026 Pavilion

Updated Category News Views 176

Seoul Business Agency Showcases Startups at CES 2026 Pavilion The Seoul Business Agency (SBA) has taken ambitious strides to support the innovative spirit of Seoul's startups at CES 2026. Engaging with 19 prestigious institutions within Seoul’s ecosystem, the SBA is dedicated to empowering 70 startups as they venture onto the global stage. The 'Seoul POP' themed...

Continue Reading
VYJUVEK® Receives Groundbreaking Approval for DEB Treatment

Updated Category News Views 252

VYJUVEK® Approved for Dystrophic Epidermolysis Bullosa Treatment VYJUVEK approved for DEB treatment from birth, offering flexible home administration options for patients and their families. This breakthrough marks VYJUVEK as the first genetic medicine approved in Japan for DEB. Recently, Krystal Biotech, Inc. (NASDAQ: KRYS) announced that its innovative treatment,...

Continue Reading